Assay Sales Lift Luminex Q4 Revenues 16 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that revenues for its fourth quarter increased 16 percent year over year on the strength of its assays and related products as well as consumables sales.

Total revenues for the three months ended Dec. 31, 2012 were $55.5 million, up from $47.9 million in the year-ago period, and beat the consensus Wall Street estimate of $54.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.